The positive data from this analysis is a big milestone for Citius Pharma (NASDAQ: CTXR) and could act as a catalyst for the company’s shares.
The positive data from this analysis is a big milestone for Citius Pharma (NASDAQ: CTXR) and could act as a catalyst for the company’s shares.